| | 790299-79-5 Basic information More.. |
| Product Name: | Masitinib | | Synonyms: | MASITINIB;4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]benzamide;4-((4-Methylpiperazin-1-yl)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)-1,3-thiazol-2-yl)amino)phenyl)benzamide;Ab 1010;Ab1010;Ab-1010;Mastinib;Masitinib(AB1010) | | CAS: | 790299-79-5 | | MF: | C28H30N6OS | | MW: | 498.64 | | EINECS: | 226-164-5 | | Mol File: | 790299-79-5.mol |  |
Use
Masitinib is a novel tyrosine kinase inhibitor (TKI) being developed by AB Science to treat symptoms of amyotrophic lateral sclerosis (ALS). Masitinib controlled-release implant for treating solid neoplasm.
- Masitinib (AB1010)
-
- US $10.00 / KG
- 2025-11-10
- CAS:790299-79-5
- Min. Order: 100KG
- Purity: 99%
- Supply Ability: 100 mt
- Masitinib
-
- US $118.00-73.00 / mg
- 2025-11-09
- CAS:790299-79-5
- Min. Order:
- Purity: 99.91%
- Supply Ability: 10g
- Masitinib
-
- US $0.00 / KG
- 2025-08-08
- CAS:790299-79-5
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50000KG/month
|
|
790299-79-5
Recommend Suppliers |
|